Endoscopy
Role of antireflux mucosal ablation in "reflux-predominant" refractory gastroesophageal reflux disease: a randomized sham-controlled trial.
Digvijay Chavan, Krithi Krishna Koduri, Aniruddha Pratap Singh, Rajesh Goud Maragoni, Nitin Jagtap, Rakesh Kalapala, D Nageshwar Reddy
Published: 202610.1055/a-2740-9297
Abstract
Refractory gastroesophageal reflux disease (GERD) often requires endoscopic or surgical intervention. We evaluated the efficacy of antireflux mucosal ablation (ARMA) versus sham treatment in patients with reflux-predominant refractory GERD.This singl…
Preview only. Read the full abstract at the source